{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:53:46Z","timestamp":1787316826893,"version":"build-2736575974"},"reference-count":68,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Education and Science of Bulgaria","award":["DO1-361\/2023"],"award-info":[{"award-number":["DO1-361\/2023"]}]},{"award":["DO1-361\/2023"],"award-info":[{"award-number":["DO1-361\/2023"]}],"id":[{"id":"https:\/\/ror.org\/053pcb396","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Gastrointestinal and liver diseases remain major contributors to global morbidity and mortality, with limited options for curative or regenerative treatment. Innovative cell-based platforms for liver regeneration and treatment include advanced therapy medicinal products (ATMPs) based on mesenchymal stem cells (MSCs), induced pluripotent stem cells (iPSCs), and organoids produced by them, while cell-free systems like extracellular vesicles (EVs) offer a new approach to restore tissue function and homeostasis. This review summarizes key advances from 2020 to 2025 in the translational development of these platforms. MSCs have achieved clinical validation in perianal Crohn\u2019s disease and show encouraging antifibrotic and immunomodulatory effects in cirrhosis and acute-on-chronic liver failure. iPSC and iPSC-derived organoids now enable disease modeling and, in early trials, have shown direct epithelial repair. Emerging cell-free approaches based on EVs promise safer, scalable products. Despite rapid progress, challenges remain in potency standardization, manufacturing, and long-term efficacy assessment. International harmonization through the EMA, FDA, and PMDA frameworks is accelerating the translation of stem cell-based advanced therapy medicinal products. The integration of bioengineering, data science, and ethical governance will determine whether these regenerative approaches evolve into accessible standard-of-care interventions for gastrointestinal and hepatic diseases.<\/jats:p>","DOI":"10.3390\/biomedicines14051102","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:46:55Z","timestamp":1778676415000},"page":"1102","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Stem Cell Therapies for Gastrointestinal and Liver Diseases: Translational Barriers, Clinical Heterogeneity, and Future Directions"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0584-415X","authenticated-orcid":false,"given":"Georgi","family":"Nikolaev","sequence":"first","affiliation":[{"name":"Department of Cell and Developmental Biology, Faculty of Biology, Sofia University \u201cSt. Kliment Ohridski\u201d, 1164 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3867-5292","authenticated-orcid":false,"given":"Stefan","family":"Lozenov","sequence":"additional","affiliation":[{"name":"Department of Cell and Developmental Biology, Faculty of Biology, Sofia University \u201cSt. Kliment Ohridski\u201d, 1164 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2519-5762","authenticated-orcid":false,"given":"Marina","family":"Konaktchieva","sequence":"additional","affiliation":[{"name":"Gastroenterology Department, Military Medical Academy, Sofia Center, \u201cSveti Georgi Sofiyski\u201d 3 Str., 1606 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borislav","family":"Arabadzhiev","sequence":"additional","affiliation":[{"name":"Department of Cell and Developmental Biology, Faculty of Biology, Sofia University \u201cSt. Kliment Ohridski\u201d, 1164 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6457-1329","authenticated-orcid":false,"given":"Ivelina","family":"Vassileva","sequence":"additional","affiliation":[{"name":"Department of Cell and Developmental Biology, Faculty of Biology, Sofia University \u201cSt. Kliment Ohridski\u201d, 1164 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radko","family":"Sotirov","sequence":"additional","affiliation":[{"name":"Department of Cell and Developmental Biology, Faculty of Biology, Sofia University \u201cSt. Kliment Ohridski\u201d, 1164 Sofia, Bulgaria"},{"name":"Medical Centre ReproBioMed, 1618 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7981-4506","authenticated-orcid":false,"given":"Rossitza","family":"Konakchieva","sequence":"additional","affiliation":[{"name":"Department of Cell and Developmental Biology, Faculty of Biology, Sofia University \u201cSt. Kliment Ohridski\u201d, 1164 Sofia, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1053\/j.gastro.2023.05.050","article-title":"Global burden of digestive diseases: A systematic analysis of the Global Burden of Diseases Study, 1990 to 2019","volume":"165","author":"Wang","year":"2023","journal-title":"Gastroenterology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41575-023-00759-2","article-title":"Global epidemiology of cirrhosis-aetiology, trends and predictions","volume":"20","author":"Huang","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13578-020-00480-6","article-title":"Mesenchymal stem cell therapy for liver disease: Full of chances and challenges","volume":"10","author":"Yang","year":"2020","journal-title":"Cell Biosci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1186\/s13287-023-03518-x","article-title":"Efficacy and safety of mesenchymal stem cell therapy in liver cirrhosis: A systematic review and meta-analysis","volume":"14","author":"Lu","year":"2023","journal-title":"Stem Cell Res. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.2147\/JIR.S458103","article-title":"Mesenchymal stromal cells: New generation treatment of inflammatory bowel disease","volume":"17","author":"Wei","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Ren, J., and Huang, S. (2025). Intestinal organoids in inflammatory bowel disease: Advances, applications, and future directions. Front. Cell Dev. Biol., 13.","DOI":"10.3389\/fcell.2025.1517121"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"151474","DOI":"10.1016\/j.ejcb.2024.151474","article-title":"Intestinal organoids: The path towards clinical application","volume":"104","author":"Sugihara","year":"2025","journal-title":"Eur. J. Cell Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1126\/science.aaz6964","article-title":"Cholangiocyte organoids can repair bile ducts after transplantation in the human liver","volume":"371","author":"Sampaziotis","year":"2021","journal-title":"Science"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Zhang, L., Pu, K., Liu, X., Bae, S.D.W., Nguyen, R., Bai, S., Li, Y., and Qiao, L. (2021). The Application of Induced Pluripotent Stem Cells Against Liver Diseases: An Update and a Review. Front. Med., 8.","DOI":"10.3389\/fmed.2021.644594"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e12510","DOI":"10.1002\/jev2.12510","article-title":"A critical systematic review of extracellular vesicle clinical trials","volume":"13","author":"Mizenko","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41423-023-00983-5","article-title":"Mesenchymal stromal cells in hepatic fibrosis\/cirrhosis: From pathogenesis to treatment","volume":"20","author":"Yang","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13287-024-04127-y","article-title":"Mesenchymal stem cell therapy as a game-changer in liver diseases: Review of current clinical trials","volume":"16","author":"Huang","year":"2025","journal-title":"Stem. Cell Res. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","article-title":"Expanded allogeneic adipose-derived MSCs (Cx601) for complex perianal fistulas in Crohn\u2019s disease: A phase 3 randomized, double-blind controlled trial","volume":"388","author":"Colombel","year":"2016","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/DCR.0000000000002325","article-title":"Follow-up Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients with Perianal Fistulizing Crohn\u2019s Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial","volume":"65","author":"Gilaberte","year":"2022","journal-title":"Dis. Colon Rectum"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13287-025-04303-8","article-title":"Efficacy and safety of mesenchymal stem cell therapy in acute on chronic liver failure: A systematic review and meta-analysis of randomized controlled clinical trials","volume":"16","author":"Lu","year":"2025","journal-title":"Stem Cell Res. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13287-023-03494-2","article-title":"Meta-analysis on last ten years of clinical injection of bone marrow-derived and umbilical cord MSC to reverse cirrhosis or rescue patients with acute-on-chronic liver failure","volume":"14","author":"Wang","year":"2023","journal-title":"Stem Cell Res. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13287-023-03364-x","article-title":"Potential advantages of genetically modified mesenchymal stem cells in the treatment of acute and chronic liver diseases","volume":"14","author":"Sani","year":"2023","journal-title":"Stem Cell Res. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13287-021-02193-0","article-title":"Enhanced anti-inflammatory effects of mesenchymal stromal cells mediated by the transient ectopic expression of CXCR4 and IL10","volume":"12","author":"Segovia","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1016\/j.xphs.2021.03.014","article-title":"Generation of Budding-Like Intestinal Organoids from Human Induced Pluripotent Stem Cells","volume":"110","author":"Onozato","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Akbari, S., Arslan, N., Senturk, S., and Erdal, E. (2019). Next-Generation Liver Medicine Using Organoid Models. Front. Cell Dev. Biol., 7.","DOI":"10.3389\/fcell.2019.00345"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.stemcr.2023.09.010","article-title":"Universal cell donor lines: A review of the current research","volume":"18","author":"Simpson","year":"2023","journal-title":"Stem Cell Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jhep.2016.01.004","article-title":"Transplantation of a human iPSC-derived hepatocyte sheet increases survival in mice with acute liver failure","volume":"64","author":"Nagamoto","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e70254","DOI":"10.1002\/jgh3.70254","article-title":"Bioengineered Bile Duct for Liver Regenerative Medicine and Bile Duct Reconstruction","volume":"9","author":"Li","year":"2025","journal-title":"JGH Open"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"7424","DOI":"10.1038\/s41467-024-51487-3","article-title":"Generation of human iPSC-derived 3D bile duct within liver organoid by incorporating human iPSC-derived blood vessel","volume":"15","author":"Carolina","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s12015-024-10838-9","article-title":"Quality and Regulatory Requirements for the Manufacture of Master Cell Banks of Clinical Grade iPSCs: The EU and USA Perspectives","volume":"21","author":"Martins","year":"2025","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41420-023-01556-1","article-title":"Stem cell-derived intestinal organoids: A novel modality for IBD","volume":"9","author":"Tian","year":"2023","journal-title":"Cell Death Discov."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"322","DOI":"10.21037\/hbsn-2025-154","article-title":"Innovations in liver organoids: The role of 3D bioprinting in creating functional organoids","volume":"14","author":"Zhang","year":"2025","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1080\/00365521.2024.2310172","article-title":"Bioengineering vascularized liver tissue for biomedical research and application","volume":"59","author":"Davoodi","year":"2024","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1038\/s41467-020-15337-2","article-title":"Stem cell-derived polarized hepatocytes","volume":"11","author":"Wu","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jcf.2025.08.011","article-title":"Correlation between patient-derived intestinal organoids and clinical responses to CFTR modulators in people with cystic fibrosis homozygous for F508del","volume":"24","author":"Mier","year":"2025","journal-title":"J. Cyst. Fibros."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Rodriguez Mier, N., Destoop, M., Spelier, S., Ramalho, A.S., Beekman, J.M., Vermeulen, F., de Winter-de Groot, K.M., and Proesmans, M. (2025). The Promising Role of Intestinal Organoids in the Diagnostic Work-Up of Cystic Fibrosis Screen Positive Inconclusive Diagnosis\/CFTR-Related Metabolic Syndrome (CFSPID\/CRMS). Int. J. Neonatal Screen., 11.","DOI":"10.3390\/ijns11030052"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.cell.2016.01.043","article-title":"Communication by Extracellular Vesicles: Where We Are and Where We Need to Go","volume":"164","author":"Tkach","year":"2016","journal-title":"Cell"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12951-023-01788-4","article-title":"Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K\/Akt\/mTOR pathway and remodeling choline metabolism","volume":"21","author":"Zhang","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"9636897231207194","DOI":"10.1177\/09636897231207194","article-title":"Mesenchymal Stem Cell-Derived Extracellular Vesicles: New Soldiers in the War on Immune-Mediated Diseases","volume":"32","author":"Ivosevic","year":"2023","journal-title":"Cell Transplant."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/XCS.0000000000001591","article-title":"Freeze-Dried, Not Frozen: Lyophilized Mesenchymal Stromal Cell-Derived Extracellular Vesicles and Therapeutic Function in Neuroinflammatory Models","volume":"242","author":"Ashley","year":"2025","journal-title":"J. Am. Coll. Surg."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Capelli, C., Cuofano, C., Pavoni, C., Frigerio, S., Lisini, D., Nava, S., Quaroni, M., Colombo, V., Galli, F., and Bezukladova, S. (2023). Potency assays and biomarkers for cell-based advanced therapy medicinal products. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1186224"},{"key":"ref_37","unstructured":"(2026, February 09). Successfully Navigating the Complex ATMP Regulatory Landscape. Available online: https:\/\/www.evotec.com\/sciencepool\/navigating-the-atmp-regulatory-landscape."},{"key":"ref_38","unstructured":"International Pharmaceutical Regulators Programme (IPRP) (2026, February 21). Cell and Gene Therapy Working Group: Regulatory Convergence Report 2024. Available online: https:\/\/www.iprp.global."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"eaba6884","DOI":"10.1126\/sciadv.aba6884","article-title":"Shattering barriers toward clinically meaningful MSC therapies","volume":"6","author":"Levy","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.stem.2019.05.005","article-title":"Engineering Stem Cell Self-organization to Build Better Organoids","volume":"24","author":"Brassard","year":"2019","journal-title":"Cell Stem Cell"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/DCR.0000000000001093","article-title":"A Systematic Review and Meta-analysis of Mesenchymal Stem Cell Injections for the Treatment of Perianal Crohn\u2019s Disease: Progress Made and Future Directions","volume":"61","author":"Lightner","year":"2018","journal-title":"Dis. Colon Rectum"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e36890","DOI":"10.1016\/j.heliyon.2024.e36890","article-title":"Extracellular vesicles for the treatment of ulcerative colitis: A systematic review and meta-analysis of animal studies","volume":"10","author":"Li","year":"2024","journal-title":"Heliyon"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e70075","DOI":"10.1002\/ctm2.70075","article-title":"Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles: A focus on inflammatory bowel disease","volume":"14","author":"Suau","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1097\/CM9.0000000000003332","article-title":"Cell therapy for end-stage liver disease: Current state and clinical challenge","volume":"137","author":"Zhang","year":"2024","journal-title":"Chin. Med. J. Engl."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"100291","DOI":"10.1016\/j.jhepr.2021.100291","article-title":"A phase II study of human allogeneic liver-derived progenitor cell therapy for acute-on-chronic liver failure and acute decompensation","volume":"3","author":"Nevens","year":"2021","journal-title":"JHEP Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"748","DOI":"10.18063\/ijb.748","article-title":"3D bioprinting strategy for engineering vascularized tissue models","volume":"9","author":"Chae","year":"2023","journal-title":"Int. J. Bioprint."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.stem.2020.09.014","article-title":"Pluripotent Stem Cell-Based Cell Therapy-Promise and Challenges","volume":"27","author":"Yamanaka","year":"2020","journal-title":"Cell Stem Cell"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Qin, D., Huang, P., Chen, J., Wu, C., and Liang, Y. (2025). The therapeutic potential of different mesenchymal stem cells and their derived exosomes in metabolic dysfunction-associated steatotic liver disease. Front. Endocrinol., 16.","DOI":"10.3389\/fendo.2025.1558194"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Kim, B., Ronaldo, R., Kweon, B.N., Yoon, S., Park, Y., Baek, J.H., Lee, J.M., and Hyun, C.K. (2024). Mesenchymal Stem Cell-Derived Exosomes Attenuate Hepatic Steatosis and Insulin Resistance in Diet-Induced Obese Mice by Activating the FGF21-Adiponectin Axis. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms251910447"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","article-title":"Mesenchymal stromal cells: Clinical challenges and therapeutic opportunities","volume":"22","author":"Galipeau","year":"2018","journal-title":"Cell Stem Cell"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1182\/blood-2007-02-074997","article-title":"Mesenchymal stem cells inhibit natural killer\u2013cell proliferation, cytotoxicity, and cytokine production: Role of indoleamine 2,3-dioxygenase and prostaglandin E2","volume":"111","author":"Spaggiari","year":"2008","journal-title":"Blood"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jcyt.2015.11.008","article-title":"International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials","volume":"18","author":"Galipeau","year":"2016","journal-title":"Cytotherapy"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.stem.2013.12.005","article-title":"Human pluripotent stem cell culture: Considerations for maintenance, expansion, and therapeutics","volume":"14","author":"Chen","year":"2014","journal-title":"Cell Stem Cell"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.tibtech.2012.03.003","article-title":"Process engineering of human pluripotent stem cells for clinical application","volume":"30","author":"Serra","year":"2012","journal-title":"Trends Biotechnol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nature20168","article-title":"Designer matrices for intestinal stem cell and organoid culture","volume":"539","author":"Gjorevski","year":"2016","journal-title":"Nature"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jcyt.2018.12.006","article-title":"Manufacturing and characterization of extracellular vesicles from umbilical cord-derived mesenchymal stromal cells for clinical testing","volume":"21","author":"Rohde","year":"2019","journal-title":"Cytotherapy"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"100041","DOI":"10.1016\/j.vesic.2024.100041","article-title":"Extracellular vesicle lyophilization for enhanced distribution to the point of care","volume":"3","author":"Golan","year":"2024","journal-title":"Extracell. Vesicle"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1017\/cts.2023.537","article-title":"Recent innovations in adaptive trial designs: A review of design opportunities in translational research","volume":"7","author":"Kaizer","year":"2023","journal-title":"J. Clin. Transl. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Fagoonee, S., Menchise, V., Delli Castelli, D., and Bruno, S. (2025). Emerging Biomarker Potential of Extracellular Vesicle-Enclosed MicroRNAs for Liver Fibrosis Detection. Cells, 14.","DOI":"10.3390\/cells14131025"},{"key":"ref_60","unstructured":"European Medicines Agency, and Committee for Advanced Therapies (CAT) (2026, February 10). Guideline on Quality, Non-Clinical and Clinical Requirements for Investigational ATMPs in Clinical Trials. EMA\/CAT\/22473\/2025. Available online: https:\/\/www.ema.europa.eu."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41586-019-1373-2","article-title":"A human liver cell atlas reveals heterogeneity and epithelial progenitors","volume":"572","author":"Aizarani","year":"2019","journal-title":"Nature"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Flahou, C., Morishima, T., Takizawa, H., and Sugimoto, N. (2021). Fit-For-All iPSC-Derived Cell Therapies and Their Evaluation in Humanized Mice with NK Cell Immunity. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.662360"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jcmgh.2023.01.013","article-title":"Engineered Platforms for Maturing Pluripotent Stem Cell-Derived Liver Cells for Disease Modeling","volume":"15","author":"Yuan","year":"2023","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"8837","DOI":"10.1038\/s41598-017-08879-x","article-title":"Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform","volume":"7","author":"Skardal","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s40824-023-00468-6","article-title":"Recent advances in extracellular vesicle engineering and its applications to regenerative medicine","volume":"27","author":"Rhim","year":"2023","journal-title":"Biomater. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e12404","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell. Vesicles"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Nosrati, H., and Nosrati, M. (2023). Artificial Intelligence in Regenerative Medicine: Applications and Implications. Biomimetics, 8.","DOI":"10.3390\/biomimetics8050442"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"105714","DOI":"10.1016\/j.isci.2022.105714","article-title":"Digital twin demonstrates significance of biomechanical growth control in liver regeneration after partial hepatectomy","volume":"26","author":"Hoehme","year":"2022","journal-title":"iScience"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/14\/5\/1102\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:58:31Z","timestamp":1778680711000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/14\/5\/1102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":68,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["biomedicines14051102"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines14051102","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]}}}